
Purpose: The human gastrointestinal tract harbors a complex microbial ecosystem that transcends its traditional digestive role, functioning as a dynamic endocrine organ capable of producing bioactive signaling molecules. This emerging paradigm, termed microbial endocrinology, recognizes that gut microorganisms both respond to and synthesize neuroendocrine hormones, establishing bidirectional communication pathways with host physiological systems.
Materials and Methods: This review systematically examines the interplay between intestinal microbiota and host endocrine networks, with particular emphasis on elucidating mechanistic pathways through which microbial-derived metabolites, neurotransmitters, and immune mediators govern metabolic homeostasis, stress physiology, thyroid function, and reproductive health.
Results: Gut microbes demonstrate substantial capacity to modulate host energy metabolism, with fecal microbiota transfer from obese donors inducing adiposity in recipient animals. Dysbiotic configurations correlate with metabolic syndrome, type 2 diabetes, polycystic ovary syndrome, and thyroid autoimmunity through mechanisms including short-chain fatty acid signaling, lipopolysaccharide-mediated inflammation, bile acid transformation, and enterohepatic hormone circulation. Therapeutic modulation via probiotics, prebiotics, and fecal transplantation shows promise but requires personalization due to substantial inter individual heterogeneity in microbial composition.
Conclusion: The intestinal microbiome operates as an integral component of host endocrine architecture, with dysbiosis representing a modifiable risk factor for metabolic and hormonal pathologies. Precision microbiome interventions tailored to individual endocrine profiles represent a transformative frontier for managing metabolic syndrome, diabetes, and endocrine disorders. (Open J Biomed Res 2024;3:15-20)
Vancouver (ICMJE)